Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-07-22
2009-11-03
Kemmerer, Elizabeth C. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C536S023500, C530S350000, C435S455000
Reexamination Certificate
active
07611851
ABSTRACT:
ACanissphingosine-1-phosphate (S1P) receptor isoform 1 (cS1P1), the nucleic acid encoding the cS1P1receptor, and methods for using the cS1P1receptor and the nucleic acid encoding the cS1P1receptor in assays for identifying analytes which modulate activity of the cS1P1receptor.
REFERENCES:
patent: 6423508 (2002-07-01), Bergsma et al.
patent: 2002/0155512 (2002-10-01), Liao et al.
patent: WO 01/68922 (2001-09-01), None
patent: WO 03/021220 (2003-03-01), None
patent: WO 03/062252 (2003-07-01), None
Baumruker T et al. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis. Expert Opin. Investig. Drugs, 2007; 16(3):283-289.
Brinkman, et al., “The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors”, J. of Bio. Chem., vol. 277, No. 24, pp. 21453-21457, 2002.
Chen, et al., “A Colorimetric Assay for Measuring Activation of Gs- and Gq-Coupled Signaling Pathways”, Analytical Biochemistry, vol. 226, pp. 349-354, 1995.
Coward, et al., “Chimeric G Proteins Allow a High-Throughput Signaling Assay of Gi-Coupled Receptors”, Annal. Biochem., vol. 270, pp. 242-249, 1999.
Forrest, et al., “Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes”, JPET, vol. 309, No. 2, pp. 758-768, 2004.
Fukushima, et al., “Lysophospholipid Receptors, ” Annu. Rev. Pharmacol. Toxicol., vol. 41, pp. 507-534, 2001.
Golla, et al., “A Homogenous Enzyme Fragment Complementation Cyclic AMP Screen for GPCR Agonists”, J. of Biomol. Screening, vol. 7, No. 6, pp. 515-525, 2002.
Gopalakrishnan, et al., “A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptors”, Analytical Biochemistry, vol. 321, pp. 192-201, 2003.
Graeler, et al., “A Lymphoid Tissue-Specific Receptor, EDG6, with Potential Immune Modulatory Functions Mediated by Extracellular Lysophospholipids,” Curr. Top. Microbiol. Immunol., vol. 246, pp. 131-136, 1999.
Hla, et al., “Sphingosine 1-phosphate receptors”, Prostaglandins & Other Lipid Mediators, vol. 64, pp. 135-142, 2001.
Hla, et al., “Signaling and biological actions of sphingosine 1-phosphate”, Pharmacoligical Research, vol. 47, pp. 401-407, 2003.
Im, et al., “Characterization of a Novel Sphingosine 1-Phosphate Receptor, Edg-8”, J. of Biol. Chem., vol. 275, No. 19, pp. 14281-14286, 2000.
Kazmi, et al., “Selective Reconstitution of Human D4 Dopamine Receptor Variants with G1a Subtypes”, Biochemistry, vol. 39, pp. 3734-3744, 2000.
Knight, et al., “A functional assay for G-protein-coupled receptors using stably transformed insect tissue culture cell lines”, Analytical Chemistry, vol. 320, pp. 88-103, 2003.
Lee, et al., “Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate”, Cell, vol. 99, pp. 301-312, 1999.
Liu, et al., “Edg-1, the G protein-coupled receptor for sphingosine-1 phosphate, is essential for vascular maturation”, J. of Clin. Invest., vol. 106, No. 8, pp. 951-961, 2000.
Mandala, et al., “Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Reeptor Agonists”, Science, vol. 296, pp. 346-349, 2002.
Niedernberg, et al., “Comparative analysis of human and rat S1P5 (edg8); differential expression profiles and sensitivities to antagonists”, Biochem. Pharmacol., vol. 64, pp. 1243-1250, 2002.
Ohmori, et al., “Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2”, Cardiovascular Research, vol. 58, pp. 170-177, 2003.
Okamoto, et al., “EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+ Mobilization . . . ”, J. of Biol., Chem., vol. 273, No. 42, pp. 27104-27110, 1998.
Pyne, et al., “Sphingosine 1-phosphate signalling in mammalian cells”, Biochem. J., vol, 349, pp. 385-402, 2000.
Salomone, et al., “S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate”, European J. of Pharmacology, vol. 469, pp. 125-134, 2003.
Schaphorst, et al., “Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products”, Am. J. Physiol. Lung Cell Mol. Physiol., vol. 285, pp. L258-267, 2003.
Spiegel, et al., “Functions of a new family of sphingosine-1-phosphate receptors”, Biochimica et Biophysica Acta, vol. 1484, pp. 107-116, 2000.
Spiegel, et al., “Sphingosine-1-Phosphate: An Enigmatic Signalling Lipid”, Nat. Rev. Mol. Cell. Biol., vol. 4, No. 5, pp. 397-407, 2003.
Sugimoto, et al., “Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor Isoform”, Mol. and Cell. Biol., vol. 23, No. 5, pp. 1534-1545, 2003.
Sugiyama, et al., “Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart”, Cardiovascular Research, vol. 46, pp. 119-125, 2000.
Sugiyama, et al., “Effects of Sphingosine 1-Phosphate, a Naturally Occurring Biologically Active Lysophospholipid, on the Rat Cardiovascular System”, Jpn. J. Pharmacol., vol. 82, pp. 338-342, 2000.
Van Brocklyn, et al., “Sphingosine 1-Phosphate-induced Cell Rounding and Neurite Retraction Are Mediated by the G Protein-coupled Receptor H218”, J. of Biol. Chem., vol. 274, pp. 4626-4632, 1999.
van der Wal, et al., “Monitoring Agonist-induced Phospholipase C Activation in Live Cells by Fluorescence Resonance Energy Transfer”, J. of Biol. Chem., vol. 276, No. 18, pp. 15337-15344, 2001.
Varnai, et al., “Visualization of Phosphoinositides That Bind Pleckstrin Homology Domains: Calcium- and Agonist-induced Dynamic Changes and Relationship to Myo-[3H]inositol-labeled Phosphoinositide Pools”, J. of Cell Biol., vol. 143, No. 2, pp. 501-510, 1998.
Yatomi, et al., “Sphingosine 1-Phosphate, a Bioactive Sphingolipid Abundantly Stored in Platelets, Is a Normal constituent of human Plasma and Serum”, J. Biochem., vol. 121, pp. 969-973, 1997.
Mandala Suzanne M.
Meyers Cheryl
Shei Gan-Ju Maria
Ballard Kimberly A.
Camara Valerie J.
Chisholm Patricia L.
Kemmerer Elizabeth C.
Merck & Co. , Inc.
LandOfFree
Canis sphingosine 1-phosphate receptor isoform 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canis sphingosine 1-phosphate receptor isoform 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canis sphingosine 1-phosphate receptor isoform 1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4105385